Luis Miguel
Chinchilla Tábora
Profesor Asociado CC. Salud
Hospital Universitario de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (9)
2024
-
Differentially Expressed Genes Involved in Primary Resistance to Immunotherapy in Patients with Advanced-Stage Pulmonary Cancer
International Journal of Molecular Sciences, Vol. 25, Núm. 4
2023
-
Etiopathogenic role of ERK5 signaling in sarcoma: prognostic and therapeutic implications
Experimental and Molecular Medicine, Vol. 55, Núm. 6, pp. 1247-1257
-
Expression of MDM2 in Giant Follicular Dendritic Cell Sarcoma: A Potential Diagnostic Pitfall
International Journal of Surgical Pathology, Vol. 31, Núm. 8, pp. 1513-1515
-
Impact of Aberrant β-Catenin Pathway on Cholangiocarcinoma Heterogeneity
Cells, Vol. 12, Núm. 8
-
The Impact of Liquid Biopsies Positive for EGFR Mutations on Overall Survival in Non-Small Cell Lung Cancer Patients
Diagnostics, Vol. 13, Núm. 14
2022
-
Dysregulated Expression of Three Genes in Colorectal Cancer Stratifies Patients into Three Risk Groups
Cancers, Vol. 14, Núm. 17
-
Prognostic Impact of EGFR Amplification and Visceral Pleural Invasion in Early Stage Pulmonary Squamous Cell Carcinomas Patients after Surgical Resection of Primary Tumor
Cancers, Vol. 14, Núm. 9
-
Superior Vena Cava Syndrome Due to Mediastinal Signet-Ring Cell Carcinoma of Unknown Primary Site
Open Respiratory Archives, Vol. 4, Núm. 2